ES2058118T3 - Derivados heterociclicos de propeno amida, procedimiento para su preparacion y su uso como farmacos. - Google Patents
Derivados heterociclicos de propeno amida, procedimiento para su preparacion y su uso como farmacos.Info
- Publication number
- ES2058118T3 ES2058118T3 ES87306989T ES87306989T ES2058118T3 ES 2058118 T3 ES2058118 T3 ES 2058118T3 ES 87306989 T ES87306989 T ES 87306989T ES 87306989 T ES87306989 T ES 87306989T ES 2058118 T3 ES2058118 T3 ES 2058118T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- halo
- substituted
- hydrogen
- pharmacs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/66—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I) EN LA QUE X ES R''(OH)C=C(CN)-, R1(CO)-CH(CN)- O EL GRUPO (II), SIENDO R1 Y R2 HIDROGENO O UN ALQUILO DE 1 A 6 C, R3,R4,R5 Y R6 SON CADA UNO HIDROGENO, HIDROXI, HALOGENO, NITRO, CIANO, CARBOXI, ALQUILO, ALCOXI, ALQUILTIO Y ALQUILO HALO SUSTITUIDO DE 1 A 4 C, ALCOXICARBONILO DE 2 A 5 C FENILO O FENOXI OPCIONALMENTE SUSTITUIDOS, R''R"N- (DONDE R'' Y R" SON CADA UNO HIDROGENO O ALQUILO DE 1 A 4 C), R"''CONH- (SIENDO R"'' ALQUILO DE 1 A 4 C) O UN GRUPO DE FORMULA -CR7R8R9 (EN EL QUE R7, R8 Y R9 SON CADA UNO ALQUILO O HALOALQUILO DE 1 A 6 C O FENILO QUE PUEDE ESTAR SUSTITUIDO, O BIEN R7 Y R8 EN UNION DEL ATOMO DE CARBONO AL QUE ESTAN UNIDOS, FORMAN UN GRUPO CICLOALQUILO QUE CONTIENE DE 3 A 7 ATOMOS DE CARBONO, O R7, R8 Y R9 JUNTO CON EL ATOMO DE CARBONO AL QUE ESTAN UNIDOS FORMAN UN GRUPO BICICLOALQUILICO QUE CONTIENE DE 4 A 9 ATOMOS DE CARBONO), E Y ES UN ANILLO HETEROCICLICO DE 5 A 6 MIEMBROS, EXCLUYENDO EL PIRAZOL. TANTO LOS COMPUESTOS DE LAINVENCION COMO SUS SALES TIENEN PROPIEDADES FARMACEUTICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868619433A GB8619433D0 (en) | 1986-08-08 | 1986-08-08 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2058118T3 true ES2058118T3 (es) | 1994-11-01 |
Family
ID=10602474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87306989T Expired - Lifetime ES2058118T3 (es) | 1986-08-08 | 1987-08-06 | Derivados heterociclicos de propeno amida, procedimiento para su preparacion y su uso como farmacos. |
Country Status (20)
Country | Link |
---|---|
US (1) | US4983619A (es) |
EP (1) | EP0259972B1 (es) |
JP (1) | JPS63246364A (es) |
CN (1) | CN1021050C (es) |
AT (1) | ATE91489T1 (es) |
AU (1) | AU605498B2 (es) |
CA (1) | CA1290335C (es) |
DE (1) | DE3786507T2 (es) |
DK (1) | DK414087A (es) |
EG (1) | EG18231A (es) |
ES (1) | ES2058118T3 (es) |
GB (1) | GB8619433D0 (es) |
HU (1) | HU204520B (es) |
IL (1) | IL83433A (es) |
MX (1) | MX173324B (es) |
NZ (1) | NZ221353A (es) |
PH (1) | PH23488A (es) |
PT (1) | PT85477B (es) |
SU (1) | SU1593568A3 (es) |
ZA (1) | ZA875812B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
US5108999A (en) * | 1990-02-02 | 1992-04-28 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
CA2083179C (en) * | 1990-05-18 | 2001-10-23 | Robert Ryder Bartlett | Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
JPH06135948A (ja) * | 1992-10-30 | 1994-05-17 | Taiho Yakuhin Kogyo Kk | スチレン誘導体又はその塩 |
WO1995024894A2 (en) * | 1994-03-14 | 1995-09-21 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents |
US20160287549A1 (en) | 2013-11-22 | 2016-10-06 | Genzyme Corporation | Novel methods for treating neurodegenerative diseases |
WO2021050556A1 (en) * | 2019-09-09 | 2021-03-18 | Rutgers, The State University Of New Jersey | Compositions and methods for inhibiting ribosome inactivating proteins |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL186239B (nl) * | 1975-06-05 | Hoechst Ag | Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze. | |
DK545976A (da) * | 1975-12-11 | 1977-06-12 | Hoechst Ag | Cyaneddikesyreanilidderivater fremgangsmade til deres fremstilling og midler der indeholder disse forbindelser |
DE2655009A1 (de) * | 1976-12-04 | 1978-06-15 | Hoechst Ag | Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel |
GB1598900A (en) * | 1978-05-23 | 1981-09-23 | Lilly Industries Ltd | Heterocyclic amino derivatives |
EP0021207B1 (de) * | 1979-06-11 | 1985-08-07 | Ciba-Geigy Ag | Alphacarbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate die diese Verbindungen enthalten |
DE3331874A1 (de) * | 1982-09-13 | 1984-04-05 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue thiophenderivate |
DE3609542A1 (de) * | 1986-03-21 | 1987-10-01 | Bayer Ag | 5-acylamino-pyrazol-derivate |
-
1986
- 1986-08-08 GB GB868619433A patent/GB8619433D0/en active Pending
-
1987
- 1987-08-02 EG EG449/87A patent/EG18231A/xx active
- 1987-08-03 PH PH35614A patent/PH23488A/en unknown
- 1987-08-04 IL IL83433A patent/IL83433A/xx not_active IP Right Cessation
- 1987-08-04 PT PT85477A patent/PT85477B/pt not_active IP Right Cessation
- 1987-08-05 NZ NZ221353A patent/NZ221353A/en unknown
- 1987-08-05 CA CA000543738A patent/CA1290335C/en not_active Expired - Fee Related
- 1987-08-06 AT AT87306989T patent/ATE91489T1/de active
- 1987-08-06 DE DE87306989T patent/DE3786507T2/de not_active Expired - Fee Related
- 1987-08-06 MX MX007667A patent/MX173324B/es unknown
- 1987-08-06 EP EP87306989A patent/EP0259972B1/en not_active Expired - Lifetime
- 1987-08-06 ZA ZA875812A patent/ZA875812B/xx unknown
- 1987-08-06 SU SU874203115A patent/SU1593568A3/ru active
- 1987-08-06 ES ES87306989T patent/ES2058118T3/es not_active Expired - Lifetime
- 1987-08-07 JP JP62198007A patent/JPS63246364A/ja active Pending
- 1987-08-07 CN CN87105515A patent/CN1021050C/zh not_active Expired - Fee Related
- 1987-08-07 HU HU873600A patent/HU204520B/hu not_active IP Right Cessation
- 1987-08-07 DK DK414087A patent/DK414087A/da not_active Application Discontinuation
- 1987-08-07 AU AU76680/87A patent/AU605498B2/en not_active Ceased
-
1990
- 1990-01-11 US US07/464,644 patent/US4983619A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4983619A (en) | 1991-01-08 |
NZ221353A (en) | 1990-04-26 |
CN87105515A (zh) | 1988-03-23 |
IL83433A0 (en) | 1988-01-31 |
EG18231A (en) | 1992-10-30 |
PT85477A (en) | 1987-09-01 |
SU1593568A3 (ru) | 1990-09-15 |
ATE91489T1 (de) | 1993-07-15 |
PT85477B (pt) | 1990-06-29 |
IL83433A (en) | 1992-03-29 |
ZA875812B (en) | 1989-04-26 |
EP0259972A2 (en) | 1988-03-16 |
DE3786507T2 (de) | 1993-11-11 |
DE3786507D1 (de) | 1993-08-19 |
MX7667A (es) | 1993-09-01 |
CN1021050C (zh) | 1993-06-02 |
HU204520B (en) | 1992-01-28 |
MX173324B (es) | 1994-02-16 |
GB8619433D0 (en) | 1986-09-17 |
AU7668087A (en) | 1988-02-11 |
PH23488A (en) | 1989-08-16 |
DK414087D0 (da) | 1987-08-07 |
JPS63246364A (ja) | 1988-10-13 |
CA1290335C (en) | 1991-10-08 |
AU605498B2 (en) | 1991-01-17 |
EP0259972B1 (en) | 1993-07-14 |
DK414087A (da) | 1988-02-09 |
EP0259972A3 (en) | 1990-05-02 |
HUT46684A (en) | 1988-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68914793D1 (de) | Chinazolinon-Derivate. | |
MX9200109A (es) | Derivados de acridina, procedimiento para su prepaderivados de acridina, procedimiento para su preparacion y composicion farmaceutica que los contieneracion y composicion farmaceutica que los contiene. . | |
MX9206939A (es) | Derivados de piperazina, procedimiento para su preparacion y composicion farmaceutica que los comprende | |
PH25859A (en) | Composition for treatment of ischemic disorder | |
ATE94535T1 (de) | 4-amino-3-acylchinolin-derivate und ihre verwendung als inhibitoren der magensekretion. | |
KR890014522A (ko) | 사이클릭 이미드의 아릴피페라지닐알콕시 유도체, 이의 제조방법 및 약제로서의 이의 용도 | |
ES2058118T3 (es) | Derivados heterociclicos de propeno amida, procedimiento para su preparacion y su uso como farmacos. | |
ES8601850A1 (es) | Un procedimiento para preparar derivados de ciclobutano | |
FI833453A (fi) | Terapeutiska medel | |
DK160486C (da) | N-(4-amino-2,2-diphenyl-butyl)- eller n-(3-amino-2,2-diphenyl-propyl) urinstofforbindelser, fremgangsmaade til fremstilling af disse, samt en farmaceutisk komposition | |
EP0446921A3 (en) | Optically active alkylene-dioxybenzene derivatives and their use in therapy | |
HUT50176A (en) | Process for production of derivatives of heterocyclic lactane and medical compositions containing them as active substance | |
ES2054095T3 (es) | Procedimiento para la preparacion de nuevos derivados tieniloxi-alquilaminicos. | |
FI871253A (fi) | 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar. | |
ATE57928T1 (de) | 1-alkyl-ergolinyl-thioharnstoffderivate. | |
SE8803484L (sv) | Nya kinolin- och isokinolinderivat och foerfarande foer framstaellning daerav | |
ATE2004T1 (de) | Piperazinyl-imidazo(1,2-a)pyrazin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
PT87954A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico | |
ATE6514T1 (de) | Clavulansaeure-derivate, ihre herstellung und pharmazeutische zubereitungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 259972 Country of ref document: ES |